Glioblastoma is a highly aggressive brain tumor. Current standard-of-care results in a marginal therapeutic outcome. partly due to acquirement of resistance and insufficient blood-brain barrier (BBB) penetration of chemotherapeutics. To circumvent these limitations. https://www.mudrsat.com/product-category/container/